[ad_1]
The drug maker stated the extra funding will assist its late-stage medical development together with the expanded Phase three research of Moderna’s vaccine candidate.
world
Updated: Jul 26, 2020 20:52 IST
Moderna Inc stated on Sunday it has obtained an extra $472 million from the U.S. authorities’s Biomedical Advanced Research and Development Authority (BARDA) to assist development of its novel coronavirus vaccine.
The drug maker stated the extra funding will assist its late-stage medical development together with the expanded Phase three research of Moderna’s vaccine candidate.
Thank you for subscribing to our every day publication.
[ad_2]
Source hyperlink